Kala Pharmaceuticals KALA reported its Q1 earnings results on Monday, May 16, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Kala Pharmaceuticals missed estimated earnings by 11.11%, reporting an EPS of $-0.4 versus an estimate of $-0.36.
Revenue was down $1.89 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.27 which was followed by a 2.67% drop in the share price the next day.
Here's a look at Kala Pharmaceuticals's past performance:
|Quarter||Q4 2021||Q3 2021||Q2 2021||Q1 2021|
To track all earnings releases for Kala Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.